Transcatheter closure of patent ductus arteriosus with the use of Rashkind occluders and/or Gianturco coils: Long-term follow-up in 123 patients and special reference to comparison, residual shunts, complications, and technique

Transcatheter patent ductus arteriosus occlusion: Evolution of techniques and results from the 1990s

“…Longitudinal studies showed that trivial residual leaks had a strong tendency to spontaneous closure over time 13–15 . However, as confirmed in this review, larger residual shunts required a second device for effective closure 11,13 and this requirement for a second procedure to close residual shunts has meant the use of the Rashkind occluder is now historical.…”

Transcatheter patent ductus arteriosus occlusion: Evolution of techniques and results from the 1990s

“…Longitudinal studies showed that trivial residual leaks had a strong tendency to spontaneous closure over time 13–15 . However, as confirmed in this review, larger residual shunts required a second device for effective closure 11,13 and this requirement for a second procedure to close residual shunts has meant the use of the Rashkind occluder is now historical.…”

Pulmonary Embolization of Vascular Occlusion Coils in Dogs with Patent Ductus Arteriosus

“…9 Detailed follow-up data is available for humans with PDA treated via coil embolization. [10][11][12][13][14] Reported rates of pulmonary embolization range from 1 to 15%, with most coils being retrieved from their aberrant position. 15 No embolizations occurred during the postoperative or recovery period in any study.…”

Stent implantation for coarctation of aorta caused by a Rashkind patent ductus arteriosus umbrella

“…The Rashkind PDA umbrella has been superceded by smaller devices and by simpler techniques for transcatheter closure of PDA [5, 6]. Disadvantages of the umbrella system included significant residual leaks, device size, and a relatively large delivery system [6–10].…”

“…The Rashkind PDA umbrella has been superceded by smaller devices and by simpler techniques for transcatheter closure of PDA [5, 6]. Disadvantages of the umbrella system included significant residual leaks, device size, and a relatively large delivery system [6–10]. Although disturbances to flow in the descending aorta have been demonstrated by echocardiography [7, 8], these have been transient and significant coarctation has not been previously reported [8].…”

Transcatheter patent ductus arteriosus occlusion: Evolution of techniques and results from the 1990s

“…Longitudinal studies showed that trivial residual leaks had a strong tendency to spontaneous closure over time 13–15 . However, as confirmed in this review, larger residual shunts required a second device for effective closure 11,13 and this requirement for a second procedure to close residual shunts has meant the use of the Rashkind occluder is now historical.…”

Pulmonary Embolization of Vascular Occlusion Coils in Dogs with Patent Ductus Arteriosus

“…9 Detailed follow-up data is available for humans with PDA treated via coil embolization. [10][11][12][13][14] Reported rates of pulmonary embolization range from 1 to 15%, with most coils being retrieved from their aberrant position. 15 No embolizations occurred during the postoperative or recovery period in any study.…”

Stent implantation for coarctation of aorta caused by a Rashkind patent ductus arteriosus umbrella

“…The Rashkind PDA umbrella has been superceded by smaller devices and by simpler techniques for transcatheter closure of PDA [5, 6]. Disadvantages of the umbrella system included significant residual leaks, device size, and a relatively large delivery system [6–10].…”

“…The Rashkind PDA umbrella has been superceded by smaller devices and by simpler techniques for transcatheter closure of PDA [5, 6]. Disadvantages of the umbrella system included significant residual leaks, device size, and a relatively large delivery system [6–10]. Although disturbances to flow in the descending aorta have been demonstrated by echocardiography [7, 8], these have been transient and significant coarctation has not been previously reported [8].…”

Transcatheter patent ductus arteriosus occlusion: Evolution of techniques and results from the 1990s

“…Longitudinal studies showed that trivial residual leaks had a strong tendency to spontaneous closure over time 13–15 . However, as confirmed in this review, larger residual shunts required a second device for effective closure 11,13 and this requirement for a second procedure to close residual shunts has meant the use of the Rashkind occluder is now historical.…”

Pulmonary Embolization of Vascular Occlusion Coils in Dogs with Patent Ductus Arteriosus

“…9 Detailed follow-up data is available for humans with PDA treated via coil embolization. [10][11][12][13][14] Reported rates of pulmonary embolization range from 1 to 15%, with most coils being retrieved from their aberrant position. 15 No embolizations occurred during the postoperative or recovery period in any study.…”

Stent implantation for coarctation of aorta caused by a Rashkind patent ductus arteriosus umbrella

“…The Rashkind PDA umbrella has been superceded by smaller devices and by simpler techniques for transcatheter closure of PDA [5, 6]. Disadvantages of the umbrella system included significant residual leaks, device size, and a relatively large delivery system [6–10].…”

“…The Rashkind PDA umbrella has been superceded by smaller devices and by simpler techniques for transcatheter closure of PDA [5, 6]. Disadvantages of the umbrella system included significant residual leaks, device size, and a relatively large delivery system [6–10]. Although disturbances to flow in the descending aorta have been demonstrated by echocardiography [7, 8], these have been transient and significant coarctation has not been previously reported [8].…”